Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.15 | 30.02 |
| PEG Ratio (TTM) | 1.16 | -0.31 |
| P/S Ratio (TTM) | 0.81 | 3.56 |
| P/B Ratio (TTM) | 1.12 | 32.21 |
| P/FCF Ratio (TTM) | 22.44 | 24.95 |
| Price to 5YR AVG Earnings Ratio | 8.48 | 26.67 |
| Price to 5YR AVG FCF Ratio | 1,932.61 | 24.37 |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.25% | 10.87% |
| ROE (TTM) | 5.69% | 120.30% |
| Net Profit Margin (TTM) | 4.21% | 13.12% |
| ROIC 5YR AVG | 1.73% | 26.61% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 144.93% | -182.67% | 378.05% |
| Revenue | 1.25% | -5.21% | -4.18% |
| Net Income | 115.50% | -178.41% | 362.26% |
| Cash Flow | 555.02% | 8,723.87% | 5,129.95% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.30 | 0.90 |
| Quick Ratio (TTM) | 1.62 | 0.63 |
| D/E Ratio (TTM) | 0.26 | 3.91 |
| Interest Coverage (TTM) | 2.92 | 15.13 |
| Piotroski F-Score | 8 | 8 |
| Altman Z-Score | 2.90 | 5.31 |
| LTL to 5YR AVG FCF | 514.84 | 4.29 |
| Shares Outstanding Growth 5YR AVG | -9.45% | -0.31% |